PAHCPHIBRO ANIMAL HEALTH CORP

Nasdaq pahc.com


$ 16.80 $ 0.32 (1.95 %)    

Tuesday, 07-May-2024 15:59:46 EDT
QQQ $ 440.32 $ 0.07 (0.02 %)
DIA $ 388.70 $ 0.29 (0.07 %)
SPY $ 517.26 $ 0.57 (0.11 %)
TLT $ 90.79 $ 0.55 (0.61 %)
GLD $ 214.23 $ -0.99 (-0.46 %)
$ 16.77
$ 16.45
$ 0.00 x 0
$ 0.00 x 0
$ 16.42 - $ 16.99
$ 9.21 - $ 17.40
130,623
na
679.25M
$ 0.84
$ 45.90
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-07-2024 12-31-2023 10-Q
2 11-08-2023 09-30-2023 10-Q
3 08-30-2023 06-30-2023 10-K
4 05-03-2023 03-31-2023 10-Q
5 02-08-2023 12-31-2022 10-Q
6 11-09-2022 09-30-2022 10-Q
7 08-24-2022 06-30-2022 10-K
8 05-04-2022 03-31-2022 10-Q
9 02-09-2022 12-31-2021 10-Q
10 11-02-2021 09-30-2021 10-Q
11 08-25-2021 06-30-2021 10-K
12 05-06-2021 03-31-2021 10-Q
13 02-03-2021 12-31-2020 10-Q
14 11-04-2020 09-30-2020 10-Q
15 08-26-2020 06-30-2020 10-K
16 05-07-2020 03-31-2020 10-Q
17 02-03-2020 12-31-2019 10-Q
18 11-04-2019 09-30-2019 10-Q
19 08-27-2019 06-30-2019 10-K
20 05-06-2019 03-31-2019 10-Q
21 02-06-2019 12-31-2018 10-Q
22 11-06-2018 09-30-2018 10-Q
23 08-27-2018 06-30-2018 10-K
24 05-07-2018 03-31-2018 10-Q
25 02-05-2018 12-31-2017 10-Q
26 11-06-2017 09-30-2017 10-Q
27 08-30-2017 06-30-2017 10-K
28 05-08-2017 03-31-2017 10-Q
29 02-06-2017 12-31-2016 10-Q
30 11-09-2016 09-30-2016 10-Q
31 08-29-2016 06-30-2016 10-K
32 05-09-2016 03-31-2016 10-Q
33 02-09-2016 12-31-2015 10-Q
34 11-09-2015 09-30-2015 10-Q
35 09-10-2015 06-30-2015 10-K
36 05-11-2015 03-31-2015 10-Q
37 02-10-2015 12-31-2014 10-Q
38 11-12-2014 09-30-2014 10-Q
39 09-18-2014 06-30-2014 10-K
40 05-13-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Zoetis Inc. (NYSE:ZTS) and Phibro Animal Health Corporation (NASDAQ:PAHC) today announced that they have entered into a definit...

 phibro-animal-health-affirms-2024-adj-eps-and-net-sales-guidance

We affirm our previously issued fiscal year 2024 guidance for the following measures:Net sales of $980 million to $1.020 billio...

 phibro-animal-health-q2-2024-adj-eps-033-beats-028-estimate-sales-24990m-beat-24230m-estimate

Phibro Animal Health (NASDAQ:PAHC) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of ...

 earnings-scheduled-for-february-7-2024

Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per shar...

 phibro-animal-health-corporation-announces-glenn-c-david-has-joined-phibro-and-will-assume-the-role-of-chief-financial-officer-effective-february-9-2024

Phibro Animal Health Corporation (NASDAQ:PAHC) (the "Company" or "Phibro") today announced that Glenn C. David ...

 why-amc-entertainment-shares-are-trading-lower-by-around-14-here-are-other-stocks-moving-in-thursdays-mid-day-session

Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results.

 morgan-stanley-maintains-equal-weight-on-phibro-animal-health-lowers-price-target-to-16

Morgan Stanley analyst Erin Wright maintains Phibro Animal Health (NASDAQ:PAHC) with a Equal-Weight and lowers the price tar...

 phibro-animal-health-q1-eps-014-misses-023-estimate-sales-23130m-miss-24204m-estimate

Phibro Animal Health (NASDAQ:PAHC) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate o...

 earnings-scheduled-for-november-8-2023

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.

 phibro-animal-health-corporation-reiterates-safety-of-mecadox-and-intent-to-defend-its-use-for-customers

(NASDAQ:PAHC) The Food and Drug Administration (FDA), through its Center for Veterinary Medicine (CVM), has taken two actions r...

 roth-mkm-reiterates-buy-on-phibro-animal-health-maintains-21-price-target

Roth MKM analyst Brian Wright reiterates Phibro Animal Health (NASDAQ:PAHC) with a Buy and maintains $21 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION